The use of biomarkers in the diagnosis and treatment of overactive bladder: Can we predict the patients who will be resistant to treatment?

NGF and HB-EGF: Potential Biomarkers that Reflect the Effects of Fesoterodine in Patients with Overactive Bladder Syndrome

(2015) Soo Rim Kim et al.   YONSEI MEDICAL JOURNAL

Urinary nerve growth factor levels could be a biomarker for overactive bladder symptom: a meta-analysis

(2014) H.C. Qu et al.   GENETICS AND MOLECULAR RESEARCH

Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?

(2013) Jai H. Seth et al.   BJU INTERNATIONAL

Biomarkers in overactive bladder

(2013) Alka A. Bhide et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder

(2013) Long-wang Wang et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Urinary Neurotrophic Factors in Healthy Individuals and Patients with Overactive Bladder

(2012) Tiago Antunes-Lopes et al.   JOURNAL OF UROLOGY

Differential profile analysis of urinary cytokines in patients with overactive bladder

(2011) Gamal Ghoniem et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Urinary Nerve Growth Factor Levels in Overactive Bladder Syndrome and Lower Urinary Tract Disorders

(2011) Hsin-Tzu Liu et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy

(2011) Hsin-Tzu Liu et al.   NEUROUROLOGY AND URODYNAMICS

Management of overactive bladder

(2010) Dev M. Gulur et al.   Nature Reviews Urology

Urinary levels of glycosaminoglycans in patients with idiopathic detrusor overactivity

(2009) Salvatore Siracusano et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study

(2009) Pradeep Tyagi et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY